Safety Study Investigating Local Tolerability and Pharmacokinetics of PXL01 in Healthy Volunteers
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to determine whether three different single doses of PXL01
are safe and well tolerated by healthy volunteers. The pharmacokinetic properties of PXL01
(same doses) will also be investigated.